Objective: The aim of this study is to describe the characteristic of patients with Erectile Dysfunction (ED) and results of Nocturnal penile tumescence and rigidity (NPTR) based on Rigiscan® examination in patients with ED in Jakarta. Material & Methods: Descriptive-prospective study of patients with ED in Cipto Mangunkusumo Referral Hospital, Bunda General Hospital Jakarta, and ASRI-Siloam Urology Hospital are recorded during 2015. Patients’ age (in years), marital status (yes/no), duration of ED (in months), and International Index of Erectile Function-5 (IIEF-5) were recorded. NPTR examination were performed while patients were sleeping. Number of events, duration of each event (in minutes) as well as the rigidity (in percentage) and tumescence (in cm) were recorded. The elevation of tip and base penile circumference (in cm) during erection were also noted. Results: There were 34 patients who agreed to perform NPTR test. Most patients were married with the average age of 40.94 ± 10.81 years old. The duration of ED were varied from 5 to 96 months with average duration of 33.7 ± 44.34 months and IIEF-5 score was 6.38 ± 5.14. In general number of erections was 4 ± 3 with 23.4% of them had normal erection. The comparison between organic and psychogenic ED showed that the increment of circumference was significantly less in organic ED patients. Other parameters showed insignificant difference in statistical results. Conclusion: NPTR examination is an objective, effective, and easy-to-use measurement in order to differentiate between organic and psychogenic ED. One third of patients who complained with ED suffered from psychogenic ED and needed referral to other specialists.
Erectile dysfunction, impotence, Rigiscan®, penile rigidity
Hatzichristou D, Moncada I, Salonia A, Vardi Y, Wespes E. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. European Association of Urology; 2014. p. 6.
Sivalingam S, Hashim H, Schwaibold H. An overview of the diagnosis and treatment of erectile dysfunction. 2006; 66(18): 2339–55.
Johannes CB, Araujoa B, Feldman Ha, Derby Ca, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study. J Urol. 2000; 163(2): 460–3.
Moreira ED, Lbo CFL, Diament A, Nicolosi A, Glasser DB. Incidence of erectile dysfunction in men 40 to 69 years old: Results from a population-based cohort study in Brazil. Urology [Internet]. 2003; 61(2): 431–6. Available from: http://www.sciencedirect.com/science/article/pii/S0090429502021581
Schouten BWV, Bosch JLHR, Bernsen RMD, Blanker MH, Thomas S, Bohnena M. Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen study. Int J Impot Res [Internet]. 2005; 17(1): 58–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15510192
Feldman Ha, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol. 1994; 151(1): 54–61.
Aytaç Ia., McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999; 84(1): 50–6.
Hyde Z, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SAP, et al. Prevalence of sexual activity and associated factors in men aged 75 to 95 years: A Cohort Study. Ann Intern Med [Internet]. American Urological Association Education and Research, Inc. 2010; 153(11): 693–702. Available from: http://www.annals.org/cgi/content/abstract/153/11/693
Kiskac M, Zorlu M, Cakirca M, Büyükaydın B, Karatoprak C, Yavuz E. Frequency and determinants of erectile dysfunction in Turkish diabetic men. 2015; 18(2): 209–12.
Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, et al. European Association of Urology Guidelines on Male Infertility: The 2012 Update. Eur Urol. 2012; 62: 324–32.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: Results of the “Cologne Male Survey”. Int J Impot Res. 2000; 12(6): 305–11.
Fazio L, Brock G. Erectile dysfunction: Management update. CMAJ. 2004; 170(9): 1429–37.
Caskurlu T, Tasci AI, Resim S, Sahinkanat T, Ergenekon E. The etiology of erectile dysfunction and contributing factors in different age groups in Turkey. Int J Urol. 2004; 11(7): 525–9.
Ludwig W, Phillips M. Organic causes of erectile dysfunction in men under 40. Urol Int. 2014; 92(1): 1–6.
Montorsi F. Assessment, diagnosis, and investigation of erectile dysfunction. 2005; 7(1): 29–34.
Ralph D. UK management guidelines for erectile dysfunction. BMJ. 2000; 321: 499–503.
Yang Y, Liu R, Jiang H, Hong K, Zhao L, Tang W, et al. Association between dosage frequency and the treatment outcomes of sildenafil in young and middle-aged men with erectile dysfunction: A Chinese, Multicenter, Observational Study. Urology [Internet]. Elsevier Inc. 2015; 86(1): 62–7. Available from: http://dx.doi.org/10.1016/j.urology.2015.03.011.
Lombardo F, Gandini L, Jannini Ea, Sgrò P, Gilio B, Toselli L, et al. Diagnosing erectile dysfunction: Instruments for endocrine diagnosis. Int J Androl [Internet]. 2005;28 Suppl 2:53–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16236065.
Wespes E. Cavernosal smooth muscle biopsy is a useful tool in the diagnosis of erectile dysfunction. Curr Sex Heal Reports [Internet]. 2004; 1(2): 40–3. Available from: http://link.springer.com/10.1007/s11930-004-0003-6.
Caretta N, Palego P, Schipilliti M, Ferlin A, Di Mambro A, Foresta C. Cavernous Artery Intima-Media Thickness: A New Parameter in the Diagnosis of Vascular Erectile Dysfunction. J Sex Med [Internet]. 2009; 6(4): 1117–26. Available from: http://doi.wiley.com/10.1111/j.1743-6109.2008.01112.xnpapers2.
Andersson DP, Ekström U, Lehtihet M. Rigiscan evaluation of men with diabetes mellitus and erectile dysfunction and correlation with diabetes duration, age, BMI, lipids and HbA1c. PLoS One [Internet]. 2015; 10(7): e0133121. Available from: http://dx.plos.org/10.1371/journal.pone.0133121.
McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res [Internet]. 2000; 12 Suppl 4: S6–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11035380.
Karadeniz T, Topsakal M, Aydogma A BM. Role of rigiscan in the etiologic differential diagnosis of erectile dysfunction. Urol Int [Internet]. 1997; 59: 41–5. Available from: http://www.americanbanker.com/issues/179_124/which-city-is-the-next-big-fintech-hub-new-york-stakes-its-claim-1068345-1.html.
Carvalheira A, Forjaz V, Pereira NM. Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: How do men use the inhibitors? 2014; (2): 96–102.
Chen XB, Li RX, Yang HN, Dai JC. A comprehensive, prospective study of penile dimensions in Chinese men of multiple ethnicities. Int J Impot Res [Internet]. 2014; 26(5): 172–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24784891.
Burris S, Sherins J. Quantitative and rigidity assessment in normal of nocturnal penile tumescence men using a home monitor of the measurement. 1989; 492–7.
Basar MM, Atan A, Tekdogan ÜY. New concept parameters of rigiscan in differentiation of vascular erectile dysfunction: Is it a useful test? Int J Urol. 2001; 8(12): 686–91.